ImmuPharma plc (IMM.L) CEO Slams Stock Plunge After Drug Trial 11/19/2009
More...
|
Human Genome Sciences, Inc. (HGSI) (JOBS), GlaxoSmithKline (GSK) Lupus Drug Works in 2nd Trial 11/2/2009
More...
|
Human Genome Sciences, Inc. (HGSI) (JOBS), GlaxoSmithKline (GSK) Report Progress With Lupus Treatment 10/22/2009
More...
|
Human Genome Sciences, Inc. (HGSI) (JOBS): Journal Reviews Lupus Drug Endpoints Positively 9/4/2009
More...
|
Human Genome Sciences, Inc. (HGSI) Achieves Lupus Drug Goals With DSG's EDC 8/18/2009
More...
|
ZymoGenetics, Inc. (ZGEN) Shares Benefit From Human Genome Sciences, Inc. (HGSI) Trial Success Reported Monday, July 20 7/21/2009
More...
|
Human Genome Sciences, Inc. (HGSI) and GlaxoSmithKline (GSK) (JOBS) Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus; Drug Met Its Primary Efficacy Endpoint 7/21/2009
More...
|
Odds Stacked Against Human Genome Sciences, Inc. (HGSI)'s Lupus Drug; Analysts Skeptical About Trial Outcome Due Monday July 20 7/20/2009
More...
|
Human Genome Sciences, Inc. (HGSI) to Host Conference Call to Discuss Top-Line Phase 3 Results for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Systemic Lupus Erythematosus 7/20/2009
More...
|
Novel DNA Vaccine Leads To Kidney Damage Prevention In Systemic Lupus Erythematosus Models, Universidad de Guadalajara Study 6/18/2009
More...
|
Human Genome Sciences, Inc. (HGSI) Says Lupus Drug Shows Positive Results 6/12/2009
More...
|
La Jolla Pharmaceutical Company (LJPC) and BioMarin Pharmaceutical Inc. (BMRN) (JOBS) Stop Developing Lupus Drug 2/12/2009
More...
|
Blocked Protein Prevents Lupus In Mouse Model, The Jackson Laboratory And National Institutes of Health (NIH) Study 1/22/2009
More...
|
BioMarin Pharmaceutical Inc. (BMRN) and La Jolla Pharmaceutical Company (LJPC) Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent; BioMarin May Spend $289 Million for La Jolla's Drug 1/7/2009
More...
|
Massachusetts General Hospital And Idera Pharmaceuticals, Inc. (IDRA) Receive Cooperative Research Grant from Massachusetts Life Sciences Center for Developing New Therapies for Lupus 12/22/2008
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update on Its Auction Rate Securities and Its Ongoing Riquent® Phase 3 “ASPEN” Lupus Trial 12/18/2008
More...
|
New Inhibitor Drug Seen For Arthritis, Lupus, Australian Researchers Report in Immunology and Cell Biology 11/25/2008
More...
|
Lupus Foundation of American Release: Dr. Betty Diamond Selected to Receive Prestigious Evelyn V. Hess Award Recognizing a Lifetime of Achievement in Lupus Research 10/16/2008
More...
|
ZymoGenetics, Inc. (ZGEN), Merck Serono Change Lupus Deal 9/3/2008
More...
|
Lupus Foundation of America Launches Center for Clinical Trials Education 8/25/2008
More...
|
Medarex, Inc. (MEDX) Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus Medarex to Receive Milestone Payment from MedImmune 8/12/2008
More...
|
Verto, a Subsidiary of Hadasit Ltd. Bio-Holdings, Completes Successful Human Clinical Trial of a Treatment for Lupus 7/21/2008
More...
|
Human Genome Sciences, Inc. (HGSI) Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus 6/12/2008
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Cancer Drug Velcade Might Work in Lupus According to Study 6/9/2008
More...
|
ZymoGenetics, Inc. (ZGEN) and Merck Serono Initiate Second Phase 2/3 Clinical Study of Atacicept in Lupus 6/5/2008
More...
|
Abnormal 'Editing' Of Gene Messages May Be A Cause Of Lupus, Wake Forest University Study 5/21/2008
More...
|
Rigel Pharmaceuticals, Inc. (RIGL)'s R788 Slows Progression of Murine Lupus in Preclinical Studies 4/29/2008
More...
|
La Jolla Pharmaceutical Company (LJPC) Announces Positive 12-Month Interim Antibody Data and Provides Update for Ongoing Riquent(R) Phase 3 'ASPEN' Lupus Trial 4/23/2008
More...
|
ImmuPharma plc (IMM.L) Release: First Lupus Patients Dosed with IPP-201101 in Phase IIb Study 2/26/2008
More...
|
Overabundance of Immune Cells Might Trigger Lupus 2/15/2008
More...
|
La Jolla Pharmaceutical Company (LJPC) Reports Progress in International Phase 3 Riquent(R) Study 2/11/2008
More...
|
New Genetic Mutation That Halts The Development Of Lupus Discovered By Scripps Research Institute 1/21/2008
More...
|
Gene Studies Home In On Lupus Cause 1/21/2008
More...
|
Alliance For Lupus Research Release: International Consortium Identifies Genes Linked to Lupus 1/21/2008
More...
|
ZymoGenetics, Inc. (ZGEN) Announces Special Protocol Assessment for Atacicept in General SLE 1/15/2008
More...
|
Tolerx, Inc. Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus 1/15/2008
More...
|
New Approach for Attacking Lupus Identified 12/17/2007
More...
|
Lupus Gene Finding Prompts Call for More DNA Samples. Wellcome Trust Sanger Institute Study 12/3/2007
More...
|
Dynavax Technologies Corporation (DVAX) Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9 Animal Model Shows Disease Progression Can Be Prevented 11/27/2007
More...
|
Existing Drugs Show Promise for Treating End-Stage Renal Disease in Lupus 11/12/2007
More...
|
La Jolla Pharmaceutical Company (LJPC) to Present March 2007 Riquent(R) Interim Antibody Data at Two Leading Medical Meetings 10/31/2007
More...
|
Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus 10/29/2007
More...
|
Teva Pharmaceutical Industries Limited (TEVA)'s Edratide for Systemic Lupus Erythematosus Did Not Meet Its Primary Endpoint in Phase 2 Trial 9/19/2007
More...
|
Study Identifies Genetic Risk Factor for Rheumatoid Arthritis, Lupus 9/6/2007
More...
|
UT Southwestern Medical Center: Preclinical Study Suggests Organ-Transplant Drug May Aid in Lupus Fight 8/16/2007
More...
|
Immunomedics, Inc. (IMMU) Release: Study Reports Epratuzumab Affects B-Cells from Patients With Lupus in a Unique Manner 8/16/2007
More...
|
The European Medicines Evaluation Agency Recommends Astion Pharma's Drug Candidate ASF-1096 for Orphan Drug Status 8/1/2007
More...
|
Research Links Genetic Mutations to Lupus, Wake Forest University Baptist Medical Center Study 7/30/2007
More...
|
MedImmune, Inc. Advances Potential Treatment for Patients With Lupus 7/19/2007
More...
|
Sperm Abnormalities Seen in Male Lupus Patients 6/28/2007
More...
|
Aspreva Pharmaceuticals Corporation (ASPV) and Roche (RHHBY) Lupus Drug Fails to Meet Main Goal 6/27/2007
More...
|
Human Genome Sciences, Inc. (HGSI)'s (Jobs) Lupus Drug Shows Positive Mid-Stage Trial Results 6/14/2007
More...
|
La Jolla Pharmaceutical Company (LJPC) Shares Sink; Analyst Predicts Riquent Trial Will Fail and Rates Stock at 'Sell' 6/13/2007
More...
|
Human Genome Sciences, Inc. (HGSI) and GlaxoSmithKline (GSK) Initiate Second Phase 3 Clinical Trial of LymphoStat-B(R) in Systemic Lupus Erythematosus 5/30/2007
More...
|
New Insights into Chronic Inflammation and Atherosclerosis 5/25/2007
More...
|
La Jolla Pharmaceutical Company (LJPC) Reports Riquent(R) Well Tolerated in Three Studies at International Lupus Congress 5/24/2007
More...
|
Genelabs Technologies, Inc. (GNLB) Receives Agreement From FDA on Special Protocol Assessment for Phase III Trial of Prestara in Lupus 4/3/2007
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update on Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial 3/20/2007
More...
|
La Jolla Pharmaceutical Company (LJPC) (Jobs) Announces Positive Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial 3/8/2007
More...
|
Human Genome Sciences, Inc. (HGSI) And GlaxoSmithKline (GSK) Announce Initiation Of Phase 3 Clinical Trial Of LymphoStat-B(R) In Systemic Lupus Erythematosus 2/13/2007
More...
|
Idera Pharmaceuticals, Inc. (IDP) Presents Preclinical Data In Lupus Disease Models On Use Of Novel Class Of Antagonists For Toll-Like Receptors 2/12/2007
More...
|
Baylor Research Institute Receives $6.2 Milion Grant To Establish Center For Lupus Research 11/20/2006
More...
|
FDA Allows Resumption Of Immunomedics, Inc. (IMMU)'s Lupus Trials With Epratuzumab 11/15/2006
More...
|
Human Genome Sciences, Inc. (HGSI) Announces Positive 76-Week Results Of Phase 2 Clinical Trial Of LymphoStat-B(TM) In Systemic Lupus Erythematosus 11/14/2006
More...
|
Lupus Raises Pregnancy Death Risk: Study 11/13/2006
More...
|
New Biomarkers For Lupus Found 11/10/2006
More...
|
Human Genome Sciences, Inc. (HGSI) Announces Positive Special Protocol Assessment From FDA For Phase 3 Clinical Trials Of LymphoStat-B(TM) In Systemic Lupus Erythematosus 10/26/2006
More...
|
La Jolla Pharmaceutical Company (LJPC) Withdraws MAA Application In Europe 10/12/2006
More...
|
Aspreva Pharmaceuticals Corporation (ASPV) Announces Achievement Of Targeted Patient Enrolment In Phase III Clinical Trial For CellCept In Lupus Nephritis 9/29/2006
More...
|
Groundbreaking Lupus Diagnostic And Monitoring Technology Developed At Lahey Clinic Now Available Through Competitive Technologies, Inc. 9/5/2006
More...
|
New Cell-Based Targets For Treating Autoimmune Inflammatory Diseases 8/31/2006
More...
|
Rheologics, Inc. Release: Study: Lupus Patients With History Of Heart Attack Or Stroke Shown To Have High Blood Viscosity 8/16/2006
More...
|
Human Genome Sciences, Inc. (HGSI) Announces Phase 3 Clinical Development Program For LymphoStat-B(TM) In Systemic Lupus Erythematosus 8/9/2006
More...
|
La Jolla Pharmaceutical Company (LJPC) Expands Enrollment In Phase 3 International Riquent(R) Study 8/9/2006
More...
|
ZymoGenetics, Inc. (ZGEN) Releases Preliminary Findings From Atacicept (TACI-Ig) Phase 1b Studies In Patients With Lupus 7/25/2006
More...
|
Human Genome Sciences, Inc. (HGSI) Says Lupus Drug Shows Promise 6/22/2006
More...
|
Human Genome Sciences, Inc. (HGSI) Announces Full Presentation Of Results Of Phase 2 Clinical Trial Of LymphoStat-B(TM) In Systemic Lupus Erythematosus 6/22/2006
More...
|
La Jolla Pharmaceutical Company (LJPC) Files Marketing Authorization Application For European Regulatory Approval Of Riquent 6/22/2006
More...
|
Researchers Identify Roles Of Gene Mutations Causing Lupus In Mice 6/16/2006
More...
|
UCB Group (UCBJF.PK) And Immunomedics, Inc. (IMMU) Announce Worldwide Development Collaboration And License Agreement For Epratuzumab; Immunomedics To Receive Initial Cash Payments Totaling US $38 Million 5/10/2006
More...
|
ImmuPharma plc (IMM.L) Announces Successful Results From Its Phase I Clinical Trial With IPP-201101 For Lupus 5/10/2006
More...
|
Pittsburgh Life Sciences Greenhouse Invests $100,000 In StageMark To Help In The Diagnosis And Monitoring Of Lupus And Autoimmune Diseases 3/21/2006
More...
|
Baylor Research Institute Receives $2.9 Million To Study Lupus 2/28/2006
More...
|
Stem Cell Treatment Shows Promise For Lupus 2/1/2006
More...
|
FDA Asks Genelabs Technologies, Inc. (GNLB) For Additional Trial Of Lupus Drug 1/13/2006
More...
|
La Jolla Pharmaceutical Company (LJPC) To Initiate Multi-Dose Study Of Riquent In Lupus Patients 1/11/2006
More...
|
Evista Aids Bone Health In Lupus Patients 12/30/2005
More...
|
Statement From The Lupus Foundation Of America On The New England Journal of Medicine Article Regarding The Study On The Use Of Oral Contraceptives In Women With Lupus 12/15/2005
More...
|
TolerRx, Inc. Initiates Three Clinical Trials In Autoimmune Indications 12/7/2005
More...
|
SUNY Downstate Medical Center Release: Research Published in The The New England Journal of Medicine Challenges 30-Year- Old Standard Of Care For Lupus Patients 11/28/2005
More...
|
Lipstick, Hair Dyes Raise Lupus Risk? 11/18/2005
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update on Riquent(R) 10/18/2005
More...
|
MedImmune, Inc. (MEDI) And Medarex, Inc. (MEDX) Announce Filing Of Investigational New Drug Application For Monoclonal Antibody For The Treatment Of Lupus 10/14/2005
More...
|
Human Genome Sciences, Inc. (HGSI) Lupus Drug Misses Main Goal 10/5/2005
More...
|
Human Genome Sciences, Inc. (HGSI) To Sponsor Conference Call To Discuss Phase 2 Clinical Results Of LymphoStat-B(TM) In Systemic Lupus Erythematous Patients 10/5/2005
More...
|
Aspreva Pharmaceuticals Corporation (ASPV) And Roche (RHHBY) Conclude Special Protocol Assessment And Reach Agreement With FDA 9/29/2005
More...
|
Genelabs Technologies, Inc. (GNLB) Announces Results From Preliminary Analysis Of Its Lupus Drug Study 8/22/2005
More...
|
Genelabs Technologies, Inc. (GNLB) Announces Results From Preliminary Analysis Of An Open Label Study Of Its Lupus Drug Prestara(TM) 8/18/2005
More...
|
First Patient Treated In Aspreva Pharmaceuticals Corporation (ASPV) Pivotal Phase III Lupus Nephritis Study 7/27/2005
More...
|
Phase I Study For Active Biotech AB's SLE Project 57-57 Successfully Concluded 7/18/2005
More...
|
Human Genome Sciences, Inc. (HGSI) Release: GlaxoSmithKline (GSK) Exercises Option To LymphoStat-B(TM) 7/7/2005
More...
|
Genelabs Technologies, Inc. (GNLB) Receives Confirmation Of Orphan Drug Designation For Prestara And Provides Update On Its Development 6/22/2005
More...
|
Immunomedics, Inc. (IMMU) Initiates Two Pivotal Phase III Trials In Lupus 6/1/2005
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update On Riquent; Warns Of Financing Shortage 5/31/2005
More...
|
Human Genome Sciences, Inc. (HGSI) Reports On Progress Toward Commercialization 5/26/2005
More...
|
Genelabs Technologies, Inc. (GNLB) Announces Preliminary Results Of Genovate Biotechnology Co., Ltd.'s Clinical Trial GBL03-00 In Women With Systemic Lupus Erythematosus; Did Not Demonstrate A Statistically Significant Benefit 4/7/2005
More...
|
Repeat EBV Infection May Be Linked With Lupus 4/7/2005
More...
|
Immunomedics, Inc.'s (IMMU) Humanized Anti-CD20 Antibody Effective In Severe Lupus 3/28/2005
More...
|
Researchers Prevent Lupus In Mice 1/28/2005
More...
|
Dynavax Technologies Corporation (DVAX) Debuts Novel IRS Technology: New Platform For Autoimmune Disease Drug Discovery 1/10/2005
More...
|
Human Genome Sciences, Inc. (HGSI) Reports On Progress Of Clinical Trials And Announces Goals For 2005 At JPMorgan Healthcare Conference 1/10/2005
More...
|
Immunomedics, Inc.' (IMMU) Epratuzumab On FDA Fast Track For Lupus Therapy 1/5/2005
More...
|
Immunomedics, Inc. (IMMU) Reviews Clinical Advances At 2004 Annual Meeting Of Shareholders 12/1/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Provides Update On Riquent Program 11/23/2004
More...
|
Cyclacel Group plc Release: Beneficial Effects Of Seliciclib (CYC202) Reported In Models Of Kidney Disease 11/8/2004
More...
|
Lupus Biomarkers Identified 11/4/2004
More...
|
Active Biotech AB Commences Clinical Studies For 57-57 Project Against SLE 11/2/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Presents At American College of Rheumatology And American Society of Nephrology (ASN) Annual Meetings 10/29/2004
More...
|
Immunomedics, Inc. (IMMU) Reports Updated Clinical Results On Lupus At The ACR/ARHP 68th Annual Scientific Meeting 10/20/2004
More...
|
Immunomedics, Inc. (IMMU) Announces Plan To Conduct Registration Trials In Lupus 10/20/2004
More...
|
Encysive Pharmaceuticals (ENCY) Release: New Thelin(TM) Data Presented At American College of Rheumatology Meeting 10/18/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Letter From FDA About Riquent; Stock Down Almost 60% As FDA Request Another Trial 10/15/2004
More...
|
Genelabs Technologies (GNLB) Announces Preliminary Results Of Clinical Trial GL02-01 In Women With Systemic Lupus Erythematosus; Study Fails To Meet Primary Endpoint; Stock Falls 10/5/2004
More...
|
Histone Inhibitor Slows Lupus Nephritis In Mice 9/24/2004
More...
|
Drug Helps Manage Lupus 9/9/2004
More...
|
Genelabs Technologies (GNLB) Announces Publication Of Prestara(TM) GL95-02 Clinical Trial Results For Women With Lupus 9/9/2004
More...
|
Disease Mechanism Underlying Rheumatoid Arthritis Identified 8/24/2004
More...
|
Human Genome Sciences (HGSI) Completes Patient Enrollment In A Phase 2 Clinical Trial Of LymphoStat-B For The Treatment Of Systemic Lupus Erythematosus 7/29/2004
More...
|
Variant Alleles Increase Thrombosis Risk In Lupus Patients 7/19/2004
More...
|
Lack Of Immune System Protein Prevents Lupus-like Condition In Mice 7/12/2004
More...
|
Study To Explore Blood Stem Cells As Therapy For Severe Lupus 6/28/2004
More...
|
Genelabs Technologies (GNLB) Announces Decision To Withdraw European Marketing Application For Anastar(TM) 6/8/2004
More...
|
NIH Launches Study Of Hematopoietic Stem Cell Transplantation For Severe, Treatment-Resistant Lupus 5/18/2004
More...
|
Immunomedics, Inc. (IMMU) Reports First Clinical Results With Epratuzumab In Systemic Lupus Erythematosus (SLE) 5/11/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Data On Riquent Presented At Lupus Medical Conference 5/10/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) To Present At 7th International Congress On Systemic Lupus Erythematosus And Related Conditions 4/21/2004
More...
|
Drugs Cut Kidney Failure Risk In Lupus 3/4/2004
More...
|
Human Genome Sciences (HGSI) Announces Selection Of Lymphostat-B For Participation In FDA's Continuous Marketing Application Pilot 2 Program 3/4/2004
More...
|
New Study Published In The New England Journal of Medicine Offers Hope To Lupus Patients With Kidney Disease 3/4/2004
More...
|
La Jolla Pharmaceutical Company's (LJPC) New Drug Application For Lupus Drug Candidate Riquent(R) Accepted For Review By FDA 2/17/2004
More...
|
Genelabs Technologies (GNLB) Completes Enrollment In Confirmatory Phase III Clinical Trial Of Prestara(TM) For Lupus 2/9/2004
More...
|
Genelabs Technologies (GNLB) And Tanabe Seiyaku Company Enter Into Collaboration And License Agreement For Lupus Drug In Japan; Up To $12 Million 1/28/2004
More...
|
Lupus Research Institute Reports Unprecedented Success In First Round Of Grants 1/14/2004
More...
|
Human Genome Sciences (HGSI) Updates Progress Of Six Drugs In Clinical Trials At JPMorgan Conference 1/12/2004
More...
|
La Jolla Pharmaceutical Company (LJPC) Release: New Research Brings Hope To Lupus Patients 12/24/2003
More...
|
Arteries Clog Earlier In People With Lupus, Says New Study 12/22/2003
More...
|
Hospital For Special Surgery Release: Lupus Patients At Increased Risk For Heart Attacks 12/18/2003
More...
|
Lupus Research Institute-Sponsored Studies Tackle Mechanisms And Early Detection Of Premature Heart Disease In Young Women With Lupus 12/18/2003
More...
|
Lupus Foundation Of America Commends La Jolla Pharmaceutical Company (LJPC) 12/17/2003
More...
|
GMP Companies, Inc. Enters Into Agreement With The University of Michigan To Develop Therapies For Autoimmune Diseases 12/11/2003
More...
|
Infants May Develop Permanent Heart Damage 11/19/2003
More...
|
Cambridge Antibody Technology Group (CATG) Announces Preliminary Statement Of Results For The Year Ended 30 September 2003 11/17/2003
More...
|
Can Broccoli Prevent Lupus? 11/7/2003
More...
|
Lupus Ups Risk Of Heart Disease 11/5/2003
More...
|
NIH Release: Autoantibodies Precede Disease In Lupus Patients 11/5/2003
More...
|